Form 4: US Physical Therapy CFO Sells Shares

U.S. Physical Therapy's Chief Financial Officer, Carey P. Hendrickson, reported the sale of 698 shares of common stock for $86.11 per share.

Summary

• Carey P. Hendrickson, Chief Financial Officer of U.S. Physical Therapy Inc. (USPH), reported a sale of common stock.
• On August 25, 2025, Hendrickson disposed of 698 shares of USPH common stock.
• The shares were sold at a price of $86.11 per share.
• Following this transaction, Hendrickson directly beneficially owns 27,808 shares of common stock.
• The total beneficial ownership includes 14,510 shares granted as restricted stock under the Company's Amended and Restated 2003 Stock Incentive Plan, which vest on various dates through March 6, 2029.

Sentiment

Score: 4

Explanation: The Chief Financial Officer sold a relatively small number of shares, which can be a minor negative signal. However, the executive retains a substantial beneficial ownership, including a significant portion of restricted stock with long-term vesting, which aligns their interests with the company's long-term performance.

Positives

• The Chief Financial Officer retains a significant beneficial ownership of 27,808 shares, including a substantial portion of restricted stock, indicating continued alignment with shareholder interests.
• The sale represents a relatively small percentage of the total shares beneficially owned by the CFO, suggesting it may be for personal liquidity rather than a lack of confidence in the company.

Negatives

• An insider sale by a key executive like the Chief Financial Officer, even if small, can sometimes be interpreted as a slight negative signal regarding the executive's near-term outlook on the company's stock performance.

Future Outlook

The filing indicates future vesting schedules for restricted stock granted to the CFO, extending through March 2029, contingent on continued employment. This suggests a long-term retention strategy for key management.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. Insider transactions are a routine part of executive compensation and personal financial management across all industries.

Comparison to Industry Standards

• This filing reports a standard insider transaction (Form 4) for a public company executive.
• The sale of a relatively small number of shares by a CFO is not uncommon for personal financial planning and does not inherently indicate a deviation from industry norms for executive stock management.
• No specific comparable companies, projects, or results are mentioned in this filing to provide a detailed comparison.

Stakeholder Impact

• Shareholders: The sale by a key executive might lead to minor concerns about management's short-term outlook, but the small size of the transaction and significant remaining holdings likely limit any substantial negative impact.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Continued vesting of 14,510 restricted shares for the CFO on various dates through March 6, 2029, contingent on continued employment.

Key Dates

Recommendation

While an insider sale by a CFO can be a minor negative signal, the transaction involves a relatively small number of shares compared to the executive's total beneficial ownership, which still includes a substantial amount of restricted stock. This suggests the sale is likely for personal liquidity rather than a lack of confidence in the company's long-term prospects. Therefore, a 'hold' recommendation is appropriate, as this single transaction does not provide sufficient information to warrant a change in investment thesis.

Keywords

U.S. Physical Therapy, USPH, Insider Trading, Form 4, Stock Sale, CFO, Carey P. Hendrickson, Restricted Stock, Equity Compensation